Navigation Links
Drug Safety Firm BioSoteria to Present on eLearning Development Experience
Date:4/29/2010

BioSoteria, a drug safety services and pharmacovigilance training provider, will be speaking today at the 2010 Lectora User Conference in Cincinnati, OH. Michelle Flewell, CPLP, Vice President of eLearning and Informatics, will present BioSoteria’s experience with Trivantis Corporation’s Lectora development tools and CourseMill learning management system (LMS) to create online pharmacovigilance training courses for the biopharmaceutical industry.

Emeryville, CA (PRWEB) April 29, 2010 -- BioSoteria, Inc., a drug safety services and education firm, will be speaking today at the 2010 Lectora® User Conference, hosted by Trivantis Corporation, the leader in elearning software for authoring and content creation. BioSoteria’s experience with Trivantis’ development tools and learning management system (LMS) to create and deliver pharmacovigilance training will be presented by Michelle Flewell, CPLP, Vice President of eLearning and Informatics at BioSoteria.

Flewell will discuss how BioSoteria, a private consulting and services company with a limited development budget, has been able to produce a series of online pharmacovigilance training courses with advanced features such as a branded user interface, assessment, tracking and bookmarking. The company’s eLadder® Safety curriculum is developed in Lectora and delivered in CourseMill® LMS, also from Trivantis.

“Because international pharmacovigilance regulations are always changing, BioSoteria needed its own authoring tool to update course content without relying on expensive specialized programmers,” said Michelle Flewell. “Lectora allows my development team to integrate all types of flash, illustration, audio, and animation files and to modify the content whenever needed, which ensures eLadder Safety courses are not only engaging but always current and reliable.”

Flewell will be joined at the 2010 Lectora User Conference in Cincinnati, Ohio, by speakers from companies such as Pfizer, Procter & Gamble, Dow Chemical, Transperfect Translations and Northrop Grumman. Her presentation will include a discussion of BioSoteria’s unique LMS requirements for delivering its training courses to external clients through the internet, integrating eCommerce and registration, and allowing prospective corporate purchasers to “test drive” eLadder Safety.

About Trivantis Corporation
Trivantis creates world-class elearning software and services that enable the creation, distribution, and management of elearning content. To learn more about how BioSoteria uses Trivantis products, read the case study at the Trivantis website . Trivantis, Lectora and CourseMill are trademarks of Trivantis Corporation.

About eLadder® Safety
BioSoteria’s eLadder Safety is a first-in-class eLearning curriculum in pharmacovigilance. The media-rich courses form a cohesive drug safety training program, with one course building on the other. Rather than a series of repackaged PowerPoint presentations, eLadder online courses are a multimedia experience, with practical engaging exercises and knowledge checks.

To learn more about eLadder Safety, view the online demonstration at www.biosoteria.com/elearningdemo, or call 1-866-660-5553, extension 13. Courses can be purchased directly from the BioSoteria website by individual learners, and enterprise licenses are available.

About BioSoteria
From strategic risk management consulting services and world-class pharmacovigilance training and education to full-service drug safety department capabilities, BioSoteria provides unmatched experience, expertise and leadership to support pharmaceutical and biotechnology companies’ efforts to maximize the benefit/risk balance of their products. To learn more about BioSoteria, please visit the company’s website at http://www.biosoteria.com, or call 1-866-660-5553.

# # #

Read the full story at http://www.prweb.com/releases/pharmacovigilance/training/prweb3940334.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Another Top 10 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac
2. nanoTox COO Greg King Advises Nanotech Companies to View Safety Concerns as an Opportunity to Gain Consumer Trust
3. Drug Safety Firm BioSoteria Receives 2009 Best of Business Award
4. American Society of Anesthesiologists: Is Apathy or Avarice Precluding Advocacy of Better Patient Safety?
5. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
6. Drug Safety Firm BioSoteria Announces Exponential Growth in 2009
7. RFID tags to boost transit worker safety
8. FDA researchers identify new MRI safety risk for patients with pacemakers
9. Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced
10. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
11. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Safety Firm BioSoteria to Present on eLearning Development Experience 
(Date:2/4/2016)... , February 4, 2016 - New FDA action ... - New FDA action date of July 22, ... July 22, 2016   - ... in the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... to be held February 8-9, 2016, at the Waldorf ... Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ContraVir, ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):